In the endovascular era peripheral bypass surgery still plays a key role. In situ saphenous vein bypass is a standardized technique. The main limitation of this procedure is the vein diameter. A new hydrophylic valvulotome (HYDRO LeMaitre® Valvulotome; LeMaitre Vascular, Burlington, MA, USA) allows even to disrupt the valves in smaller veins. The aim of this study was to analyze the intraprocedural and technical successes of this new valvulotome.
Troisi, N., De Blasis, G., Salvini, M., Michelagnoli, S., LIMBSAVE registry Collaborative, G., Ascoli Marchetti, A. (2019). Safety and effectiveness of a new valvulotome: insights from the LIMBSAVE registry. INTERNATIONAL ANGIOLOGY, 38(4), 299-304 [10.23736/S0392-9590.19.04199-3].
Safety and effectiveness of a new valvulotome: insights from the LIMBSAVE registry
Ascoli Marchetti, AMembro del Collaboration Group
2019-07-24
Abstract
In the endovascular era peripheral bypass surgery still plays a key role. In situ saphenous vein bypass is a standardized technique. The main limitation of this procedure is the vein diameter. A new hydrophylic valvulotome (HYDRO LeMaitre® Valvulotome; LeMaitre Vascular, Burlington, MA, USA) allows even to disrupt the valves in smaller veins. The aim of this study was to analyze the intraprocedural and technical successes of this new valvulotome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
